Assistant Professor, Internal Medicine, Ohio State University COM
Hematology
Dr. Sumithira Vasu, MD
|
|
Give Review
Sumithira Vasu works in the field of Hematology. She attended Thanjavur Medical College. She received 1 awards: "CMS Meaningful Use Stage 1 Certification". Sumithira Vasu is a published doctor. She published 13 publications, including: 'Decitabine enhances Fc engineered anti-CD33 mAb mediated natural killer antibody dependent cellular cytotoxicity against AML blasts.' Sumithira Vasu accepts Medicare payments and is registered with Medicare.gov.
Publications
- A novel method to expand large numbers of CD56(+) natural killer Cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after ...
- Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors.
- Atorvastatin for the Prophylaxis of Acute Graft vs. Host Disease (GVHD) in Patients Undergoing HLA-Matched Related Donor Hematopoietic Stem Cell Transplantation (HSCT).
- Decitabine priming enhances the anti-leukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in Acute myeloid leukemia.
- Lower dose of antithymocyte globulin does not increase graft-versus-host Disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem ce...
- The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for Lymphoma and multiple myeloma.
- Long-term Outcome of Fludarabine-Based Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Debilitating Paroxysmal Nocturnal Hemoglobinuria.
- An effective mobilization strategy for Lymphoma patients after failed upfront mobilization with plerixafor.
- FLT3L and Plerixafor Combination Increases Hematopoietic Stem Cell Mobilization and Leads to Improved Transplantation Outcome.
- MicroRNAs activate natural killer Cells through toll-like receptor signaling.
- Emerging immunotherapies in older adults with Acute myeloid leukemia.
- Decitabine enhances Fc engineered anti-CD33 mAb mediated natural killer antibody dependent Cellular cytotoxicity against AML blasts.
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
National Institutes of Health Clinical Center -
Thanjavur Medical College
Hospital
-
Ohio State University Wexner Medical Center
Drug Facts
| NPI NUMBER | 1710159744 | |
| NPPES Provider LastName | VASU | |
| NPPES Provider FirstName | SUMITHIRA | |
| NPPES Provider ZIPCode | 432101280 | |
| NPPES Provider State | OH | |
| Specialty Description | Hematology | |
| Total Claim Count | 75.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710159744 |
| Last Name Of The Provider | VASU |
| First Name Of The Provider | SUMITHIRA |
| View All |
Similar Doctors
|
Dr. Pierluigi Porcu, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. John C. Byrd, MD |
|
|
Dr. Mark H. Knapp, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Eric H. Kraut, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jerry W. Mitchell Jr., MD |
|
|
Dr. William L. Marsh Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charalampos A. Spiridonidis, MD
This Doctor is OpenDoctor Recommended.
|